Continued here:
Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer
BioFlorida Names AIM ImmunoTech CEO Thomas K. Equels as Entrepreneur of the Year
argenx announces closing of global offering
Read more:
argenx announces closing of global offering
Silence Therapeutics plc Announces $45 Million Private Placement
Go here to read the rest:
Silence Therapeutics plc Announces $45 Million Private Placement
Oxford Biomedica notes AstraZeneca’s COVID-19 vaccine has been authorised for emergency supply in the UK
Intercept Company Statement on Analyst Note
Excerpt from:
Intercept Company Statement on Analyst Note
Eve & Co Announces CAD$1M Private Financing
Go here to see the original:
Eve & Co Announces CAD$1M Private Financing
Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
VistaGen Announces Publication in CNS Spectrums Detailing Proposed Mechanism of Action of Its Investigational Neuroactive Nasal Sprays for Anxiety and…
Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leukemia (AML)
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
Phathom Pharmaceuticals to Host Virtual Investor Day
LIDDS AB (publ) announces the appointment of Nina Herne as CEO
See the original post here:
LIDDS AB (publ) announces the appointment of Nina Herne as CEO
Todos Medical Announces Positive Initial Clinical Proof-of-Concept Data for a Rapid SARS-CoV-2 3CL Protease Detection Assay
Kane Biotech to Release Third Quarter 2020 Financial Results on November 26 – Conference Call to Follow
Retrophin Completes Acquisition of Orphan Technologies
View original post here:
Retrophin Completes Acquisition of Orphan Technologies
NTG Nordic Transport Group publishes interim report for Q3 2020 and announces share-based incentive program and share buy-back program
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update
See the original post here:
Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update